2.4.0.8130 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Textual)truefalsefalse1false USDfalsefalse$P01_01_2007To01_31_2007http://www.sec.gov/CIK0001333763duration2007-01-01T00:00:002007-01-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$P05_01_2006To05_31_2006http://www.sec.gov/CIK0001333763duration2006-05-01T00:00:002006-05-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$P02_01_2006To02_28_2006http://www.sec.gov/CIK0001333763duration2006-02-01T00:00:002006-02-28T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$P02_01_2005To02_28_2005http://www.sec.gov/CIK0001333763duration2005-02-01T00:00:002005-02-28T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$P04_01_2013To06_30_2013http://www.sec.gov/CIK0001333763duration2013-04-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDfalsefalse$P04_01_2012To06_30_2012http://www.sec.gov/CIK0001333763duration2012-04-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDfalsefalse$P01_01_2013To06_30_2013http://www.sec.gov/CIK0001333763duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDfalsefalse$P01_01_2012To06_30_2012http://www.sec.gov/CIK0001333763duration2012-01-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDfalsefalse$P01_01_2004To12_31_2004http://www.sec.gov/CIK0001333763duration2004-01-01T00:00:002004-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10false USDfalsefalse$P04_03_2002To06_30_2013http://www.sec.gov/CIK0001333763duration2002-04-03T00:00:002013-06-30T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false falsefalsePAsOn04_23_2013http://www.sec.gov/CIK0001333763instant2013-04-23T00:00:000001-01-01T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepurexbrli012false USDtruefalse$P04_01_2012To06_30_2012_OtherContractualObligationsMemberchtpOtherContractualObligationsAxishttp://www.sec.gov/CIK0001333763duration2012-04-01T00:00:002012-06-30T00:00:00falsefalseOther Contractual Obligations [Member]chtp_OtherContractualObligationsAxisxbrldihttp://xbrl.org/2006/xbrldichtp_OtherContractualObligationsMemberchtp_OtherContractualObligationsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13false USDtruefalse$P01_01_2012To12_31_2012_ContractResearchAndManufacturingPurchaseObligationsMemberchtpContractResearchAndManufacturingPurchaseObligationsAxishttp://www.sec.gov/CIK0001333763duration2012-01-01T00:00:002012-12-31T00:00:00falsefalseContract Research and Manufacturing Purchase Obligations [Member]chtp_ContractResearchAndManufacturingPurchaseObligationsAxisxbrldihttp://xbrl.org/2006/xbrldichtp_ContractResearchAndManufacturingPurchaseObligationsMemberchtp_ContractResearchAndManufacturingPurchaseObligationsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$14false USDtruefalse$P01_01_2011To12_31_2011_ContractResearchAndManufacturingPurchaseObligationsMemberchtpContractResearchAndManufacturingPurchaseObligationsAxishttp://www.sec.gov/CIK0001333763duration2011-01-01T00:00:002011-12-31T00:00:00falsefalseContract Research and Manufacturing Purchase Obligations [Member]chtp_ContractResearchAndManufacturingPurchaseObligationsAxisxbrldihttp://xbrl.org/2006/xbrldichtp_ContractResearchAndManufacturingPurchaseObligationsMemberchtp_ContractResearchAndManufacturingPurchaseObligationsAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$15false USDtruefalse$P01_01_2010To12_31_2010_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$16false USDtruefalse$P01_01_2009To12_31_2009_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$17false USDtruefalse$P01_01_2008To12_31_2008_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$18false USDtruefalse$P01_01_2007To12_31_2007_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2007-01-01T00:00:002007-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$19false USDtruefalse$P01_01_2006To12_31_2006_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2006-01-01T00:00:002006-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$20false USDtruefalse$P01_01_2005To12_31_2005_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2005-01-01T00:00:002005-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$21false USDtruefalse$P01_01_2004To12_31_2004_LicenseAgreementWithGopalNairMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2004-01-01T00:00:002004-12-31T00:00:00falsefalseLicense Agreement With Gopal Nair [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithGopalNairMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$22false USDtruefalse$P04_01_2012To06_30_2012_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2012-04-01T00:00:002012-06-30T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$23false USDtruefalse$P01_01_2011To12_31_2011_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2011-01-01T00:00:002011-12-31T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$24false USDtruefalse$P01_01_2008To12_31_2008_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$25false USDtruefalse$P01_01_2006To12_31_2006_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763duration2006-01-01T00:00:002006-12-31T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instancesharesxbrli0USD_per_ShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$26false USDtruefalse$PAsOn06_30_2013_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$27false USDtruefalse$PAsOn06_30_2013_LicenseAgreementWithDainipponSumitomoPharmaMemberchtpLicenseAgreementAxis_NDMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis_UseRightsMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxishttp://www.sec.gov/CIK0001333763instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLicense Agreement With Dainippon Sumitomo Pharma [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_LicenseAgreementWithDainipponSumitomoPharmaMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseUse Rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_UseRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberfalsefalseN D A [Member]us-gaap_RelatedPartyTransactionsByRelatedPartyAxisxbrldihttp://xbrl.org/2006/xbrldichtp_NDMemberus-gaap_RelatedPartyTransactionsByRelatedPartyAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$28false truefalseP01_01_2006To12_31_2006_FindersAgreementMemberchtpLicenseAgreementAxis_WarrantMemberusgaapInvestmentTypeAxishttp://www.sec.gov/CIK0001333763duration2006-01-01T00:00:002006-12-31T00:00:00falsefalseFinders Agreement [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_FindersAgreementMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseWarrant [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_InvestmentTypeAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepurexbrli029false USDtruefalse$PAsOn06_30_2013_FindersAgreementMemberchtpLicenseAgreementAxis_WarrantMemberusgaapInvestmentTypeAxishttp://www.sec.gov/CIK0001333763instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseFinders Agreement [Member]chtp_LicenseAgreementAxisxbrldihttp://xbrl.org/2006/xbrldichtp_FindersAgreementMemberchtp_LicenseAgreementAxisexplicitMemberfalsefalseWarrant [Member]us-gaap_InvestmentTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_WarrantMemberus-gaap_InvestmentTypeAxisexplicitMemberUSDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1false 4chtp_InitialPaymentTowardsUseOfRightsAsPerLicenseAgreementchtp_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21truefalsefalse150000150000USD$falsetruefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25truefalsefalse100000100000USD$falsetruefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryInitial payment towards use of rights as per license agreement.No definition available.false2Initial Payment Towards Use Of Rights As Per License Agreement2false 4chtp_ValueOfCommonStockIssuedDuringPeriodTowardsMilestonePaymentchtp_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18truefalsefalse150000150000falsefalsefalse19truefalsefalse100000100000falsefalsefalse20truefalsefalse100000100000falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryValue of common stock issued during period towards milestone payment.No definition available.false2Value Of Common Stock Issued During Period Towards Milestone Payment3false 4chtp_CommonStockSharesIssuedDuringPeriodToWardsMilestonePaymentchtp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17truefalsefalse3061230612falsefalsefalse18truefalsefalse2664326643falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of common stock, shares issued during period towards milestone payment.No definition available.false1Common Stock Shares Issued During Period To wards Milestone Payment4false 4chtp_FairValueOfCommonStockIssuedDuringPeriodTowardsMilestonePaymentchtp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17truefalsefalse4.904.90USD$falsetruefalse18truefalsefalse5.635.63USD$falsetruefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalFair value of common stock issued during period towards milestone payment.No definition available.false3Fair Value Of Common Stock Issued During Period Towards Milestone Payment5false 4chtp_MilestonePaymentMadeDuringPeriodchtp_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15truefalsefalse100000100000falsefalsefalse16truefalsefalse150000150000falsefalsefalse17truefalsefalse100000100000falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23truefalsefalse750000750000falsefalsefalse24truefalsefalse500000500000falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryMilestone payments made during the period.No definition available.false2Milestone Payment Made During Period6false 4chtp_PotentialFutureMilestonePaymentschtp_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15truefalsefalse15000001500000falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26truefalsefalse25000002500000falsefalsefalse27truefalsefalse15000001500000falsefalsefalse28falsefalsefalse00falsefalsefalse29truefalsefalse150000150000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of potential future milestone payments.No definition available.false2Potential Future Milestone Payments7false 4chtp_CommonStockSharesIssuedDuringPeriodTowardsRightToUseIntellectualPropertychtp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25truefalsefalse6313163131falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe value of common share issued during the period towards the use of intellectual property.No definition available.false1Common Stock Shares Issued During Period Towards Right To Use Intellectual Property8false 4chtp_FairValueOfCommonStockIssuedDuringPeriodTowardsRightToUseIntellectualPropertychtp_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25truefalsefalse4.354.35USD$falsetruefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalThe fair value of common stock issued during the period towards the use of intellectual property.No definition available.false3Fair Value Of Common Stock Issued During Period Towards Right To Use Intellectual Property9false 4chtp_ValueOfCommonStockIssuedDuringPeriodTowardsRightToUseIntellectualPropertychtp_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25truefalsefalse274621274621falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe value of common stock issued during the period towards the use of intellectual property.No definition available.false2Value Of Common Stock Issued During Period Towards Right To Use Intellectual Property10false 4us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13truefalsefalse12000001200000falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22truefalsefalse31000003100000falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Research and Development -URI http://asc.fasb.org/extlink&oid=6523717 false2Research and Development Expense (Excluding Acquired in Process Cost)11false 4us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationWarrantsIssued1us-gaap_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:sharesItemTypesharesThe number of warrants issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586 false1Warrants issued to purchase common stock12false 4invest_InvestmentWarrantsExercisePriceinvest_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse00USD$falsetruefalse2truefalsefalse4.314.31USD$falsetruefalse3truefalsefalse3.303.30USD$falsetruefalse4truefalsefalse2.622.62USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9truefalsefalse2.882.88USD$falsetruefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalExercise price of the warrants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Article 12 -Section 13 -Sentence Column A false3Common stock warrants, purchase price (in dollars per share)13false 4chtp_FairValueOfWarrantsGrantedchtp_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse433750433750falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse705000705000falsefalsefalse4truefalsefalse2670026700falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9truefalsefalse1440014400falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFair value of warrants granted.No definition available.false2Fair Value Of Warrants Granted14false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5truetruefalse0.00220.0022falsefalsefalse6falsetruefalse00  falsefalsefalse7truetruefalse0.00690.0069falsefalsefalse8truetruefalse0.00780.0078falsefalsefalse9falsetruefalse00falsefalsefalse10falsetruefalse00falsefalsefalse11falsetruefalse00falsefalsefalse12falsetruefalse00falsefalsefalse13falsetruefalse00falsefalsefalse14falsetruefalse00falsefalsefalse15falsetruefalse00falsefalsefalse16falsetruefalse00falsefalsefalse17falsetruefalse00falsefalsefalse18falsetruefalse00falsefalsefalse19falsetruefalse00falsefalsefalse20falsetruefalse00falsefalsefalse21falsetruefalse00falsefalsefalse22falsetruefalse00falsefalsefalse23falsetruefalse00falsefalsefalse24falsetruefalse00falsefalsefalse25falsetruefalse00falsefalsefalse26falsetruefalse00falsefalsefalse27falsetruefalse00falsefalsefalse28truetruefalse0.04790.0479falsefalsefalse29falsetruefalse00falsefalsefalsenum:percentItemTypepureThe risk-free interest rate assumption that is used in valuing an option on its own shares.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iv) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Weighted average risk-free interest rate15false 4us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse002 yearsfalsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse005 yearsfalsefalsefalse8falsefalsefalse005 yearsfalsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse003 yearsfalsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaExpected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.D.2) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section D -Subsection 2 false0Weighted-average expected life of options16false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5truetruefalse00falsefalsefalse6falsetruefalse00  falsefalsefalse7truetruefalse00falsefalsefalse8truetruefalse00falsefalsefalse9falsetruefalse00falsefalsefalse10falsetruefalse00falsefalsefalse11falsetruefalse00falsefalsefalse12falsetruefalse00falsefalsefalse13falsetruefalse00falsefalsefalse14falsetruefalse00falsefalsefalse15falsetruefalse00falsefalsefalse16falsetruefalse00falsefalsefalse17falsetruefalse00falsefalsefalse18falsetruefalse00falsefalsefalse19falsetruefalse00falsefalsefalse20falsetruefalse00falsefalsefalse21falsetruefalse00falsefalsefalse22falsetruefalse00falsefalsefalse23falsetruefalse00falsefalsefalse24falsetruefalse00falsefalsefalse25falsetruefalse00falsefalsefalse26falsetruefalse00falsefalsefalse27falsetruefalse00falsefalsefalse28truetruefalse00falsefalsefalse29falsetruefalse00falsefalsefalsenum:percentItemTypepureThe estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Expected dividend yield17false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5truetruefalse1.12161.1216falsefalsefalse6falsetruefalse00  falsefalsefalse7truetruefalse1.05481.0548falsefalsefalse8truetruefalse0.85970.8597falsefalsefalse9falsetruefalse00falsefalsefalse10falsetruefalse00falsefalsefalse11falsetruefalse00falsefalsefalse12falsetruefalse00falsefalsefalse13falsetruefalse00falsefalsefalse14falsetruefalse00falsefalsefalse15falsetruefalse00falsefalsefalse16falsetruefalse00falsefalsefalse17falsetruefalse00falsefalsefalse18falsetruefalse00falsefalsefalse19falsetruefalse00falsefalsefalse20falsetruefalse00falsefalsefalse21falsetruefalse00falsefalsefalse22falsetruefalse00falsefalsefalse23falsetruefalse00falsefalsefalse24falsetruefalse00falsefalsefalse25falsetruefalse00falsefalsefalse26falsetruefalse00falsefalsefalse27falsetruefalse00falsefalsefalse28truetruefalse0.66010.6601falsefalsefalse29falsetruefalse00falsefalsefalsenum:percentItemTypepureThe estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Weighted average expected volatility18false 4us-gaap_ResearchAndDevelopmentExpenseus-gaap_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:monetaryItemTypemonetaryThe aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 false2Research and development19false 4us-gaap_SellingAndMarketingExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse241139241139falsefalsefalse6truefalsefalse17531661753166falsefalsefalse7truefalsefalse600423600423falsefalsefalse8truefalsefalse67219286721928falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse2484679924846799falsefalsefalse11falsefalsefalse00falsefalsefalse12truefalsefalse100000100000falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate total amount of expenses directly related to the marketing or selling of products or services.No definition available.false2Sales and marketing20false 4chtp_BeneficialOwnershipPercentagechtp_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5falsetruefalse00falsefalsefalse6falsetruefalse00falsefalsefalse7falsetruefalse00falsefalsefalse8falsetruefalse00falsefalsefalse9falsetruefalse00falsefalsefalse10falsetruefalse00falsefalsefalse11truetruefalse0.50.5falsefalsefalse12falsetruefalse00falsefalsefalse13falsetruefalse00falsefalsefalse14falsetruefalse00falsefalsefalse15falsetruefalse00falsefalsefalse16falsetruefalse00falsefalsefalse17falsetruefalse00falsefalsefalse18falsetruefalse00falsefalsefalse19falsetruefalse00falsefalsefalse20falsetruefalse00falsefalsefalse21falsetruefalse00falsefalsefalse22falsetruefalse00falsefalsefalse23falsetruefalse00falsefalsefalse24falsetruefalse00falsefalsefalse25falsetruefalse00falsefalsefalse26falsetruefalse00falsefalsefalse27falsetruefalse00falsefalsefalse28falsetruefalse00falsefalsefalse29falsetruefalse00falsefalsefalsenum:percentItemTypepureThis element represents the percentage of beneficial ownership.No definition available.false0Beneficial Ownership Percentage21false 4chtp_CommitmentAndContingenciesBonusPaymentsObligationchtp_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalselabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse11000001100000USD$falsetruefalse6falsefalsefalse00falsefalsefalse7truefalsefalse11000001100000USD$falsetruefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10truefalsefalse11000001100000USD$falsetruefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalse19falsefalsefalse00falsefalsefalse20falsefalsefalse00falsefalsefalse21falsefalsefalse00falsefalsefalse22falsefalsefalse00falsefalsefalse23falsefalsefalse00falsefalsefalse24falsefalsefalse00falsefalsefalse25falsefalsefalse00falsefalsefalse26falsefalsefalse00falsefalsefalse27falsefalsefalse00falsefalsefalse28falsefalsefalse00falsefalsefalse29falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThis element represents the bonus payments which the company is obligated to pay upon satisfaction of conditions.No definition available.false2Commitment And Contingencies, Bonus Payments ObligationfalseCOMMITMENTS AND CONTINGENCIES (Details Textual) (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.chelseatherapeutics.com/role/CommitmentsAndContingenciesDetailsTextual2921